Successful ADR Strategies for Life Sciences Companies:What Young Lawyers Should Know
Boston, MA
10/19/2011
6:00 pm - 7:30 pm
Join Mintz Levin and The CPR Institute for panel discussion covering a variety of issues regarding the use of ADR in the life sciences industry. Topics include: the pros and cons of using ADR to resolve disputes between collaboration/licensing/distribution partners, various ADR options available to life sciences companies, and tips for drafting ADR clauses in contracts. Panelists will also share stories from the ADR trenches, and offer advice on how to best to navigate the ADR process.
Featured Panelists:
Maria Castner, Associate General Counsel, Qiagen
John Delehanty, CPR Distinguished Neutral; Mintz Levin – New York
Christopher L. Gaenzle, Assistant General Counsel - Litigation, Pfizer Inc
Joseph Vittiglio, Vice President and Corporate Counsel, AVEO Pharmaceuticals
Sarah Weil, Senior Attorney, Abbott Laboratories, Commercial Litigation Department
Welcome Remarks:
Olivier P. André, Special Counsel and Director of Dispute Resolution Services, CPR Institute
Robert H. Mnookin, Williston Professor of Law; Director, Harvard Negotiation Research Project; Chair, Program on Negotiation
Moderator:
Samuel Davenport, Mintz Levin – Boston
Co-sponsored by The CPR Institute
Event Details
Successful ADR Strategies for Life Sciences Companies
